ISR News: Feds Warn of Security Meltdown

February 2, 2009 by ADMIN · Leave a Comment

Excerpts From DarkGovernment.com

Computer attacks pose the biggest risk “from a national security perspective, other than a weapon of mass destruction or a bomb in one of our major cities,” said Shawn Henry, assistant director of the FBI’s cyber division told the International Conference on Cyber Security in New York . According to multiple reports Henry went on to say terrorist groups aim for an online 9/11, “inflicting the same kind of damage on our country, on all our countries, on all our networks, as they did in 2001 by flying planes into buildings.”

ISR News: The Rising Cost of Lost Data

February 2, 2009 by ADMIN · Leave a Comment

Excerpts From Forbes.com’s Andy Greenberg

According to a report released Monday by the Ponemon Institute and funded by encryption firm PGP, the cost of a data breach for companies has risen to $202 per lost record, up from $197 in the institute’s 2007 study. For the 47 companies audited in the study, those costs added up to $6.6 million per incident.

Top 10 Confidential Data Breaches of 2008

January 28, 2009 by ADMIN · 1 Comment

Source: Privacy Rights Clearinghouse

UPDATE: The estimated number of people affected by a data breach at Bank of New York Mellon Corp has been raised from 4.5 million to 12.5 million. As many as 4.5 million customer records are thought to be compromised. Raised from 4.5 million to 12.5 million.

Heartland Breach Bad As Tylenol Poisonings?

January 25, 2009 by ADMIN · 3 Comments

By Anthony M. Freed, Information-Security-Resources.com Financial Editor

Heartland Payment Systems stock (HPY) was hit hard in the wake of what is being described as the biggest single breach of consumer and financial data security ever. The company issued statements Friday (1/23) in an effort at damage control in which the CEO compares the potential industry-wide impact of the breach to none other than that of the Tylenol poisonings of some twenty-five years ago that nearly brought down the drug maker.